Silo Wellness Is Headed Up By A Management Team That Has Been Ahead of The CurveRevive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 ConfirmCybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead ConcurHAVN Life Sciences Continues To Execute On Growth Initiatives Ahead Of Its Upcoming Public ListingMindMed Developing IP For Personalized Psychedelic Assisted TherapiesNuminus announces Clinical Advisory Council to advance integrated wellness modelRritual Announces Dr. Mike Hart as PresidentThe Multi-Billion Dollar Functional Mushroom Market Is Up For GrabsMydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology SField Trip Is Shifting Gears To Expedite IPO ProcessMydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth PlatforNew Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical DevelopmentNew Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory BoardChampignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin OutRed Light Holland Announces Closing of Second Tranche of Private PlacementNuminus Wellness Has Big Plans To Scale Operations In The Back Half of 2020 Following A Major License Amendment By HealtMydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical InnovationCybin Corp: A Mushroom Life Sciences Leader In The MakingChampignon Announces Closing of $15 Million Bought Deal Private PlacementNuminus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Technical420 Site Search

Returned 11 result(s).

Numinus announces Clinical Advisory Council to advance integrated wellness model

Numinus Wellness Inc. ("Numinus") (NUMI.V) is pleased to announce its Clinical Advisory Council, chaired by Numinus Chief Medical Officer Dr. Evan Wood . Leveraging the expertise of its members, the council will be responsible for program development, knowledge mobilization and driving policy change in the psychedelic assisted therapy space. Numinus Logo (CNW…

Numinus Wellness Has Big Plans To Scale Operations In The Back Half of 2020 Following A Major License Amendment By Health Canada

Although 2020 has been a challenging year for the global economy, we believe that there are a number of pockets of opportunity that our readers need to be aware of. The psychedelic therapy market has been an emerging opportunity and is an industry that has been generating significant traction. Numinus…

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Numinus Wellness Inc. (TSX-V:NUMI) ("Numinus" or the "Company") has received Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numinus researchers to conduct research to standardize the extraction of psilocybin from mushrooms. The amendment means Numinus is the first publicly traded…

Numinus Wellness : Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director

Dr. Evan Wood, Numinus Chief Medical Officer, today announced the appointment of Dr. Devon Christie, MD CCFP RTC IFMCP, to the position of Medical Director at Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI) — another key step in the Company's evolution as a leader in the advancement of psychedelic therapies, treatment and…

Numinus Announces 2020 Operational Plans to Scale

Numinus Wellness Inc. ("Numinus"), recently listed on the TSX Venture Exchange (TSX-V: NUMI), is pleased to report its near-term goals to advance our mission to address the universal desire to heal. For 2020, the company plans to upgrade its lab and processing facilities (for both cannabis and psychedelic substances), seek…

Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council

Numinus Wellness Inc. ("Numinus"; TSX-V: NUMI) is pleased to announce the appointment of Dr. Gabor Maté, MD, CM, as a Member of the Numinus Clinical Advisory Council. Through over 30 years' work in family practice, palliative care and addiction medicine, Dr. Maté has pioneered therapies and innovative, trauma-based approaches to mental health. His…

7 Companies Focused On Psychedelic Therapies For Treating Mental Illness

2020 has been a challenging year for the global economy as the world tries to recover from the COVID-19 outbreak. Following the outbreak, we have noticed a bifurcation in the markets where some sectors would considerably outperform others. For example, companies like Clorox and Amazon have reported impressive growth during…

Dr. Evan Wood, recognized leader in the field of substance use research and treatment, joins Numinus as Chief Medical Officer

Numinus Wellness Inc. ("Numinus") is pleased to announce the appointment of Dr. Evan Wood, MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat as Chief Medical Officer with Numinus, effective immediately. Dr. Wood, who over a 20-year career has gained international recognition as a leading researcher into addiction, most recently as the Executive Director…

Numinus Wellness (TSXV:NUMI) To Begin Trading Today On The TSX Venture Exchange

So far this year, the psychedelic industry has been a bright spot in what has been a challenging market. We like to compare the emergence of the psychedelic industry to the cannabis industry and believe that it is an opportunity to be aware of. Many of the companies that are…

Numinus Wellness Inc. (Formerly Rojo Resources Ltd.) Closes RTO with Salvation Botanicals Ltd; to Commence Trading Under “NUMI”

Numinus Wellness Inc. (formerly Rojo Resources Ltd., RJ:H) ("Numinus" or the "Company") (TSXV:NUMI) is pleased to announce that it has closed its previously announced reverse take-over transaction with Salvation Botanicals Ltd. ("Salvation") and has acquired all of the outstanding securities of Salvation in exchange for the issuance of securities of…

Older Posts »

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link